Israel Englander Fennec Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 69,334 shares of FENC stock, worth $343,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,334

Previous 58,534 18.45%

Holding current value

$343,203

Previous $650,000 34.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.02 - $10.99 $65,015 - $118,692	10,800 Added 18.45%	69,334 $423,000
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $389,535 - $491,114	44,165 Added 307.36%	58,534 $650,000
Q4 2023 Feb 14, 2024	SELL	$6.48 - $11.61 $469,314 - $840,854	-72,425 Reduced 83.44%	14,369 $161,000
Q2 2023 Aug 14, 2023	SELL	$7.27 - $9.82 $750,293 - $1.01 Million	-103,204 Reduced 54.32%	86,794 $766,000
Q1 2023 May 15, 2023	BUY	$7.38 - $10.35 $462,792 - $649,038	62,709 Added 49.27%	189,998 $1.58 Million
Q4 2022 Feb 14, 2023	SELL	$7.63 - $10.22 $931,226 - $1.25 Million	-122,048 Reduced 48.95%	127,289 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$5.71 - $8.54 $68,205 - $102,010	11,945 Added 5.03%	249,337 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$5.17 - $6.33 $79,033 - $96,766	-15,287 Reduced 6.05%	237,392 $1.34 Million
Q1 2022 May 16, 2022	SELL	$4.29 - $6.08 $21,184 - $30,023	-4,938 Reduced 1.92%	252,679 $1.42 Million
Q4 2021 Feb 14, 2022	SELL	$3.89 - $10.01 $15 - $40	-4 Reduced -0.0%	257,617 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$6.51 - $9.62 $957,953 - $1.42 Million	-147,151 Reduced 36.35%	257,621 $2.43 Million
Q2 2021 Aug 16, 2021	BUY	$5.96 - $7.85 $2.41 Million - $3.18 Million	404,772 New	404,772 $2.95 Million
Q2 2020 Aug 14, 2020	SELL	$5.43 - $9.39 $104,147 - $180,100	-19,180 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$4.89 - $8.1 $93,790 - $155,358	19,180 New	19,180 $114,000
Q3 2019 Nov 14, 2019	SELL	$3.85 - $4.95 $183,390 - $235,788	-47,634 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$3.3 - $5.09 $3.23 Million - $4.99 Million	-979,978 Reduced 95.36%	47,634 $191,000
Q2 2019 Aug 14, 2019	BUY	$3.3 - $5.09 $3.39 Million - $5.23 Million	1,027,612 New	1,027,612 $20.4 Million
Q2 2018 Aug 14, 2018	SELL	$10.05 - $14.33 $931,212 - $1.33 Million	-92,658 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.26 - $12.1 $765,355 - $1.12 Million	92,658 New	92,658 $1.12 Million

Others Institutions Holding FENC

# of Institutions

Shares Held

14.3M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $129M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account